IMPORTANCE: Kidney and lung injury are closely inter-related during acute respiratory illness, but the molecular risk factors that these organ injuries share are not well defined. OBJECTIVES: We identified plasma biomarkers associated with severe acute kidney injury (AKI) during acute respiratory illness, and compared them to biomarkers associated with severe acute respiratory failure (ARF). DESIGN, SETTINGS, AND PARTICIPANTS: Prospective observational cohort study enrolling March 2020 through May 2021, at three hospitals in a large academic health system. We analyzed 301 patients admitted to an ICU with acute respiratory illness. MAIN OUTCOMES AND MEASURES: Outcomes were ascertained between ICU admission and day 14, and included: 1) severe AKI, defined as doubling of serum creatinine or new dialysis and 2) severe ARF, which included new or persistent need for high-flow oxygen or mechanical ventilation. We measured biomarkers of immune response and endothelial function, pathways related to adverse kidney and lung outcomes, in plasma collected within 24 hours of ICU admission. Severe AKI occurred in 48 (16%), severe ARF occurred in 147 (49%), and 40 (13%) patients experienced both. Two-fold higher concentrations of soluble tumor necrosis factor receptor-1 (sTNFR-1) (adjusted relative risk [aRR], 1.56; 95% CI, 1.24–1.96) and soluble triggering receptor on myeloid cells-1 (sTREM-1) (aRR, 1.85; 95% CI, 1.42–2.41), biomarkers of innate immune activation, were associated with higher risk for severe AKI after adjustment for age, sex, COVID-19, and Acute Physiology and Chronic Health Evaluation-III. These biomarkers were not significantly associated with severe ARF. Soluble programmed cell death receptor-1 (sPDL-1), a checkpoint pathway molecule, as well as soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular adhesion molecule-1 (sVCAM-1), molecules involved with endothelial-vascular leukocyte adhesion, were associated with both severe AKI and ARF. CONCLUSIONS AND RELEVANCE: sTNFR-1 and sTREM-1 were linked strongly to severe AKI during respiratory illness, while sPDL-1, sICAM-1 and sVCAM-1 were associated with both severe AKI and ARF. These biomarker signatures may shed light on pathophysiology of lung-kidney interactions, and inform precision medicine strategies for identifying patients at high risk for these organ injuries.

More from our Archive

• DOI: 10.1097/mcc.0000000000001068 2023

  Multimodality imaging in cardiogenic shock: state-of-the art

  Guido Tavazzi, Francesco Corradi, Christophe Vandenbriele, Carlos L. Alviar

• DOI: 10.1097/pcc.0000000000003321 2023

  Critical Care Unit Characteristics and Extracorporeal Cardiopulmonary Resuscitation Survival in the Pediatric Cardiac Population: Retrospective Analysis of the Virtual Pediatric System Database

  Javier J. Lasa, Danielle Guffey, Utpal Bhalala, Ravi R. Thiagarajan

• DOI: 10.1097/ccm.0000000000005988 2023

  Asynchrony Injures Lung and Diaphragm in Acute Respiratory Distress Syndrome*

  Haruka Hashimoto, Takeshi Yoshida, Andi Muhammad Fadlillah Firstiogusran, Hiroki Taenaka, Ryota Nukiwa, Yukiko Koyama, Akinori Uchiyama, Yuji Fujino

• DOI: 10.1097/pcc.0000000000003323 2023

  Epinephrine Dosing Use During Extracorporeal Cardiopulmonary Resuscitation: Single-Center Retrospective Cohort*

  Nicholas M. Kucher, Alexandra M. Marquez, Anne-Marie Guerguerian, Michael-Alice Moga, Mariella Vargas-Gutierrez, Mark Todd, Osami Honjo, Christoph Haller, Geraldine Goco, Alejandro A. Floh

• DOI: 10.1093/ehjacc/zuad080 2023

  Time-based reperfusion in haemodynamically unstable pulmonary embolism patients: does early reperfusion therapy improve survival?

  Marco Zuin, Gregory Piazza, Stefano Barco, Behnood Bikdeli, Lukas Hobohm, George Giannakoulas, Stavros Konstantinides

• DOI: 10.1097/ccm.0000000000005968 2023

  Reliability of Admission Procalcitonin Testing for Capturing Bacteremia Across the Sepsis Spectrum: Real-World Utilization and Performance Characteristics, 65 U.S. Hospitals, 2008–2017*

  Alexander Lawandi, Marissa Oshiro, Sarah Warner, Guoqing Diao, Jeffrey R. Strich, Ahmed Babiker, Chanu Rhee, Michael Klompas, Robert L. Danner, Sameer S. Kadri

• DOI: 10.1177/00302228221144791 2023

  A Systematic Review and Meta-Analysis on Death Anxiety During COVID-19 Pandemic

  Indrajit Patra, Iskandar Muda, Ngakan Ketut Acwin Dwijendra, Mazin AA. Najm, Shadia Hamoud Alshahrani, Samah Sajad Kadhim, Noora M. Hameed, Yasir S. Alnassar, Naseer M. Mohammed, Yasser Fakri Mustafa, Vahid Shojaeimotlagh

• DOI: 10.1097/pcc.0000000000003324 2023

  Durable Vascular Access in Neonates in the Cardiac ICU: A Novel Technique for Tunneled Femoral Central Venous Catheters*

  Marcos Mills, Nikhil Chanani, Michael Wolf, Holly Bauser-Heaton, Asaad Beshish, Alaa Aljiffry, Tawanda Zinyandu, Kevin Maher

• DOI: 10.1177/08850666231188290 2023

  High-Risk Pulmonary Embolism: Management for the Intensivist

  Akhil Khosla, Yiyu Zhao, Hamid Mojibian, Jeffrey Pollak, Inderjit Singh

• DOI: 10.1097/cce.0000000000000945 2023

  Biomarker Signatures of Severe Acute Kidney Injury in a Critically Ill Cohort of COVID-19 and Non-COVID-19 Acute Respiratory Illness

  Neha A. Sathe, Ana Mostaghim, Elizabeth Barnes, Nicholas G. O’Connor, Sharon K. Sahi, Sana S. Sakr, Jana M. Zahlan, Craig H. Smith, Michael Fitzpatrick, Eric D. Morrell, W. Conrad Liles, Pavan K. Bhatraju